share_log

What to Expect From Icecure Medical's Earnings

What to Expect From Icecure Medical's Earnings

对Icecure医疗的收益预期是什么
Benzinga ·  11/26 00:01

Icecure Medical (NASDAQ:ICCM) will release its quarterly earnings report on Tuesday, 2024-11-26. Here's a brief overview for investors ahead of the announcement.

Icecure Medical(纳斯达克股票代码:ICCM)将于2024-11-26星期二发布其季度收益报告。在宣布之前,以下是投资者的简要概述。

Analysts anticipate Icecure Medical to report an earnings per share (EPS) of $-0.07.

分析师预计,Icecure Medical将公布的每股收益(EPS)为-0.07美元。

The market awaits Icecure Medical's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

市场正在等待Icecure Medical的宣布,对超出预期并为下一季度提供乐观指导的消息寄予厚望。

It's important for new investors to understand that guidance can be a significant driver of stock prices.

对于新投资者来说,重要的是要明白,指引可以成为股价的重要驱动力。

Historical Earnings Performance

历史收益表现

The company's EPS beat by $0.01 in the last quarter, leading to a 0.98% drop in the share price on the following day.

该公司上个季度的每股收益超过0.01美元,导致第二天股价下跌0.98%。

Here's a look at Icecure Medical's past performance and the resulting price change:

以下是Icecure Medical过去的表现以及由此产生的价格变化:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate -0.07 -0.08 -0.07 -0.07
EPS Actual -0.06 -0.08 -0.07 -0.09
Price Change % -1.0% -1.0% 0.0% -6.0%
季度 2024 年第二季度 2024 年第一季度 2023 年第四季度 2023 年第三季度
每股收益估算 -0.07 -0.08 -0.07 -0.07
实际每股收益 -0.06 -0.08 -0.07 -0.09
价格变动% -1.0% -1.0% 0.0% -6.0%
bigjpg

Market Performance of Icecure Medical's Stock

Icecure Medical股票的市场表现

Shares of Icecure Medical were trading at $0.7122 as of November 22. Over the last 52-week period, shares are down 39.48%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

截至11月22日,Icecure Medical的股票交易价格为0.7122美元。在过去的52周中,股价下跌了39.48%。鉴于这些回报率通常为负数,长期股东在本财报发布时可能会看跌。

To track all earnings releases for Icecure Medical visit their earnings calendar on our site.

要追踪Icecure Medical发布的所有财报,请访问我们网站上的财报日历。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动化内容引擎生成,并由编辑审阅。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发